BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37968601)

  • 1. Epstein-Barr virus reactivation is not causative for post-COVID-19-syndrome in individuals with asymptomatic or mild SARS-CoV-2 disease course.
    Hoeggerl AD; Nunhofer V; Lauth W; Badstuber N; Held N; Zimmermann G; Grabmer C; Weidner L; Jungbauer C; Lindlbauer N; Neureiter H; Ortner T; Flamm M; Osterbrink J; Rohde E; Laner-Plamberger S
    BMC Infect Dis; 2023 Nov; 23(1):800. PubMed ID: 37968601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.
    Apostolou E; Rizwan M; Moustardas P; Sjögren P; Bertilson BC; Bragée B; Polo O; Rosén A
    Front Immunol; 2022; 13():949787. PubMed ID: 36341457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.
    Corrales I; Giménez E; Navarro D
    Clin Vaccine Immunol; 2014 May; 21(5):684-8. PubMed ID: 24623623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Abbott Architect, Siemens Immulite, bioMerieux Vidas, and Euroimmune assays for determination of Epstein-Barr virus serological diagnosis.
    Appak O; Ozkaratas MH; Sayiner AA
    J Med Virol; 2021 Nov; 93(11):6309-6316. PubMed ID: 34375007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients.
    Chen T; Song J; Liu H; Zheng H; Chen C
    Sci Rep; 2021 May; 11(1):10902. PubMed ID: 34035353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients.
    Bernal KDE; Whitehurst CB
    Virus Res; 2023 Sep; 334():199157. PubMed ID: 37364815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
    Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
    J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.
    Luderer R; Kok M; Niesters HG; Schuurman R; de Weerdt O; Thijsen SF
    Mol Diagn; 2005; 9(4):195-200. PubMed ID: 16392898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
    Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
    Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical performance evaluation of the Elecsys Epstein-Barr virus immunoassay panel.
    Schulte-Spechtel U; Berth M; Lauseker-Hao Y; Meyer-Schlinkmann K; Bohnert M; Jochum S; Schuhmann K
    Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115443. PubMed ID: 34304105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a multiplex flow immunoassay for detection of epstein-barr virus-specific antibodies.
    Binnicker MJ; Jespersen DJ; Harring JA; Rollins LO; Beito EM
    Clin Vaccine Immunol; 2008 Sep; 15(9):1410-3. PubMed ID: 18632919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories.
    Harritshøj LH; Gybel-Brask M; Afzal S; Kamstrup PR; Jørgensen CS; Thomsen MK; Hilsted L; Friis-Hansen L; Szecsi PB; Pedersen L; Nielsen L; Hansen CB; Garred P; Korsholm TL; Mikkelsen S; Nielsen KO; Møller BK; Hansen AT; Iversen KK; Nielsen PB; Hasselbalch RB; Fogh K; Norsk JB; Kristensen JH; Schønning K; Kirkby NS; Nielsen ACY; Landsy LH; Loftager M; Holm DK; Nilsson AC; Sækmose SG; Grum-Schwensen B; Aagaard B; Jensen TG; Nielsen DM; Ullum H; Dessau RB
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33574119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of herpesvirus type 6 and IgA/IgM-mediated responses to activin-A underpin long COVID, including affective symptoms and chronic fatigue syndrome.
    Vojdani A; Almulla AF; Zhou B; Al-Hakeim HK; Maes M
    Acta Neuropsychiatr; 2024 Jun; 36(3):172-184. PubMed ID: 38571295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reactivation of Epstein-Barr virus (
    Solomay TV; Semenenko TA; Filatov NN; Vedunova SL; Lavrov VF; Smirnova DI; Gracheva AV; Faizuloev EB
    Vopr Virusol; 2021 May; 66(2):152-161. PubMed ID: 33993685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of primary Epstein-Barr virus infection disease spectrum and its reactivation in children, in Suzhou, China.
    Shi T; Huang L; Chen Z; Tian J
    J Med Virol; 2021 Aug; 93(8):5048-5057. PubMed ID: 33719067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.